Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Which of the following time is advised for patients treated with 1-131 to delay conception after treatment? 2 months 4 months 1 month 6 months 2. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Bruising Fever Anemia Arrhythmia 3. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Thyroiditis Hypothyroidism Thyroid carcinoma Hyperthyroidism 4. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 3 months. With the birth of another child. Never. After 6 months. 5. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Leukemia Gastritis Radiation pneumonitis Myelosuppression 6. Which of the following property of radiation is principally used in the treatment of tumors? Biologic effect Chemical effect Fluorescent effect Photographic effect 7. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Medullary thyroid carcinoma Pain in bony metastases Polycythemia vera Dyspnea in lung Ca 8. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Antibody therapy. Radioimmunotherapy. Radiochemotherapy. Radiation therapy. 9. An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: Retreatment. Standard therapy. Consolidation therapy. Salvage therapy. 10. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Performing pulmonary function tests Blocking thyroid uptake of free radioiodine 1 out of 10 Time is Up! Time's up By Nasser AlMutairi|2021-03-30T09:35:30+03:00March 30th, 2021| Share This Post With Others! FacebookTwitterLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave a ReplyCancel reply
Leave a Reply